Loading...
Effects of febuxostat versus allopurinol in patients with elevated serum uric acid levels, chronic gout: A literature review
Love, Ebony Mergelsberg, Holly Kellmyer, Alyssa Jeganathan, Jerisan Isa, Fadi Labbad, Ziad G.
Love, Ebony
Mergelsberg, Holly
Kellmyer, Alyssa
Jeganathan, Jerisan
Isa, Fadi
Labbad, Ziad G.
Citations
Altmetric:
Genre
Journal article
Date
2022-03-08
Advisor
Committee member
Group
Department
Podiatric Medicine
Podiatric Biomechanics
Podiatric Biomechanics
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.55067/jifaf.v1i3.12
Abstract
Gout is one of the most common etiologies of inflammatory monoarticular arthritis. Recent literature is reviewed to compare a novel advancement in chronic gout medication, febuxostat, to its counterpart allopurinol, through the identification of significant findings and improvements. Literature review concluded that febuxostat serves as a viable alternative when compared to allopurinol.
Description
Citation
Love E, Mergelsberg H, Kellmyer A, Jeganathan J, Isa F, McGuire J, Khan K, Labbad Z. Effects of febuxostat versus allopurinol in patients with elevated serum uric acid levels, chronic gout: A literature review. Journal of the International Foot & Ankle Foundation [Internet]. 2022 Mar 8;1(3). Available from: https://internationalfootankle.org/journal/index.php/JIFAF/article/view/12 doi: 10.55067/jifaf.v1i3.12
Citation to related work
International Foot & Ankle Foundation
Has part
The Journal of the International Foot & Ankle Foundation, Vol. 1, No. 3
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu